Eric Lefkofsky is the CEO and founder of a medical research company, Tempus. Tempus is a Chicago-based company established in 2015 by Eric Lefkofsky. Tempus has brought a substantial positive impact to cancer patients across the US through providing accurate data and information. Tempus is a medical research company that uses artificial intelligence and machine learning analytics to advance precision medicine, particularly in oncology.
Tempus medical research firm carries out precision medicine, a methodology that characterizes diseases and provides treatments accordingly to patients through identifying their genetic, lifestyles, and environmental factors. As a medical research company, Tempus has become one of the best innovative companies in precision medicine. According to Eric Lefkofsky, Tempus’s current final goal is creating and developing a unique system that incorporates AI to find treatments for all patients.
Using new technological medical approaches, Tempus has developed more accurate, precise methods for finding cancer treatments and other chronic diseases by analyzing molecular and clinical data. Eric Lefkofsky explains that the molecular data analyze the patients’ cells’ DNA, RNA, and proteomic data. In contrast, clinical data entails information and data from lab reports, clinical notes, pathology scans, etc.
As an entrepreneur at heart, Eric Lefkofsky has tremendous experience and knowledge in several sectors apart from medical research including, the founding of Echo Global Logistics and Lightbank. In addition, he founded InnerWorkings, Uptake Technologies, and many others. In addition, Mr. Lefkofsky mentors other entrepreneurs at the University of Chicago Booth School of Business as an adjunct professor. Mr. Lefkofsky is also an author, where he has written and published a book known as Accelerated Disruption.